Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 786

1.

Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

Katičić M, Antoljak N, Kujundžić M, Stamenić V, Skoko Poljak D, Kramarić D, Stimac D, Strnad Pešikan M, Samija M, Ebling Z.

World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.

2.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

3.

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.

van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.

PMID:
28483499
4.

Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.

Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A.

Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1062-7. doi: 10.1097/MEG.0b013e3283293797.

PMID:
19307978
5.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
6.

Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.

Fraser CG, Matthew CM, Mowat NA, Wilson JA, Carey FA, Steele RJ.

Lancet Oncol. 2006 Feb;7(2):127-31.

PMID:
16455476
8.

Screening for colorectal cancer in Italy: 2005 survey.

Zorzi M, Barca A, Falcini F, Grazzini G, Pizzuti R, Ravaioli A, Sassoli de Bianchi P, Senore C, Sigillito A, Vettorazzi M, Visioli C.

Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):49-60.

9.

Organized colorectal cancer screening in Serbia - the first round within 2013-2014.

Banković Lazarević D, Krivokapić Z, Barišić G, Jovanović V, Ilić D, Veljković M.

Vojnosanit Pregl. 2016 Apr;73(4):360-7. doi: 10.2298/VSP150421113B.

PMID:
29309104
10.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
11.

Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR Jr, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.

Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.

12.

[Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].

Suchánek S, Májek O, Zavoral M, Seifert B, Ngo O, Dušek L.

Klin Onkol. 2014;27 Suppl 2:98-105. Czech.

PMID:
25494894
13.

Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.

Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, Lewis N, Gao J.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):508-15. doi: 10.1158/1055-9965.EPI-13-0956. Epub 2014 Jan 17.

14.

[Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].

Webendörfer S, Riemann JF.

Dtsch Med Wochenschr. 2014 Jan;139(3):79-83. doi: 10.1055/s-0033-1349588. Epub 2013 Oct 2. German.

PMID:
24089288
15.

Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.

Deutekom M, van Rossum LG, van Rijn AF, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB.

Scand J Gastroenterol. 2010 Nov;45(11):1345-9. doi: 10.3109/00365521.2010.497937. Epub 2010 Jun 21.

PMID:
20560814
16.

Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.

Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, Moretti R, Cremaschini M, Parente EM, Pirola ME.

Endoscopy. 2013;45(1):27-34. doi: 10.1055/s-0032-1325800. Epub 2012 Dec 19.

PMID:
23254404
17.

Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.

Bjerrum A, Milter MC, Andersen O, Fischer A, Lynge E.

Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1433-7. doi: 10.1097/MEG.0000000000000451.

PMID:
26352132
18.

Colorectal cancer screening: 20 years of development and recent progress.

Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, Seifert B, Dusek L.

World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825. Review.

19.

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

Dekker N, van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, Hermens RP, van Zelst-Stams WA, van Oijen MG, Laheij RJ, Jansen JB, Hoogerbrugge N.

Eur J Cancer. 2011 Jul;47(10):1571-7. doi: 10.1016/j.ejca.2011.01.022. Epub 2011 Feb 28.

20.

Options for screening for colorectal cancer.

Atkin W.

Scand J Gastroenterol Suppl. 2003;(237):13-6. Review.

PMID:
12797674

Supplemental Content

Support Center